HomeInsightsStock Comparison

Dr Reddys Laboratories Ltd vs Natco Pharma Ltd Stock Comparison

Dr Reddys Laboratories Ltd vs Natco Pharma Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1275 as of 18 Dec 13:53.
  • The P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 16.9 on March 2025 . This represents a CAGR of -6.69% over 6 yearsThe P/E Ratio of Natco Pharma Ltd changed from 20 on March 2020 to 7.6 on March 2025 . This represents a CAGR of -14.89% over 6 years.
  • The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 51797 crore on March 2020 to ₹ 95465 crore on March 2025 . This represents a CAGR of 10.73% over 6 yearsThe Market Cap of Natco Pharma Ltd changed from ₹ 9215 crore on March 2020 to ₹ 14287 crore on March 2025 . This represents a CAGR of 7.58% over 6 years.
  • The revenue of Dr Reddys Laboratories Ltd for the Sep '25 is ₹ 9158 crore as compare to the Jun '25 revenue of ₹ 8862 crore. This represent the growth of 3.34% The revenue of Natco Pharma Ltd for the Sep '25 is ₹ 1463 crore as compare to the Jun '25 revenue of ₹ 1390 crore. This represent the growth of 5.21%.
  • The ebitda of Dr Reddys Laboratories Ltd for the Sep '25 is ₹ 2340 crore as compare to the Jun '25 ebitda of ₹ 2464 crore. This represent the decline of -5.03% The ebitda of Natco Pharma Ltd for the Sep '25 is ₹ 679.2 crore as compare to the Jun '25 ebitda of ₹ 632.7 crore. This represent the growth of 7.35%.
  • The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1405 crore to ₹ 1336 crore over 10 quarters. This represents a CAGR of -1.97% The net profit of Natco Pharma Ltd changed from ₹ 420.3 crore to ₹ 517.9 crore over 10 quarters. This represents a CAGR of 8.71% .
  • The Dividend Payout of Dr Reddys Laboratories Ltd changed from 14.14 % on March 2020 to 12.47 % on March 2025 . This represents a CAGR of -2.07% over 6 yearsThe Dividend Payout of Natco Pharma Ltd changed from 25.89 % on March 2020 to 5.8 % on March 2025 . This represents a CAGR of -22.07% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's portfolio of products and services include Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

About Natco Pharma Ltd

  • Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited.
  • It became a deemed public company with effect from 1 July 1992.
  • The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC, Andhra Pradesh on 18 February 1993.
  • The company was converted into a public limited company and a fresh certificate of incorporation dated 30 December 1994 was issued by the RoC, Andhra Pradesh. Natco Pharma is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
  • The Company's focus is primarily on niche therapeutic areas and complex products.

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories allots 9,165 equity shares under ESOS

Dr Reddys Laboratories has allotted 9,165 equity shares under ESOS on 09 December 2025. Po...

Read more

09 Dec 2025 17:27

News

Dr Reddy's Lab arm inks pact with Immutep SAS for novel cancer immunotherapy

Eftilagimod alfa is a novel immunotherapy with the potential to set a new standard of care...

Read more

08 Dec 2025 15:24

News

Dr Reddys Laboratories Ltd up for five straight sessions

Dr Reddys Laboratories Ltd rose for a fifth straight session today. The stock is quoting a...

Read more

01 Dec 2025 13:00

News

Dr Reddys Lab gains after securing EC nod for AVT03

AVT03 is a human monoclonal IgG2 antibody and biosimilar candidate to Prolia and Xgeva, wh...

Read more

25 Nov 2025 09:50

News

Dr. Reddy's receives EC marketing authorization for AVT03 (denosumab)

Dr Reddys Laboratories announced that the European Commission (EC) has granted marketing a...

Read more

24 Nov 2025 17:34

News

Dr Reddys Laboratories Ltd up for fifth session

Dr Reddys Laboratories Ltd is up for a fifth straight session in a row. The stock is quoti...

Read more

17 Nov 2025 13:00

Natco Pharma Ltd News Hub

News

Natco Pharma announces change in senior management

Natco Pharma has appointed Amit Parekh as Executive Vice President - Finance and Accounts ...

Read more

02 Dec 2025 13:22

News

Natco Pharma receives affirmation in credit ratings from ICRA

Natco Pharma announced that ICRA has reaffirmed/ assigned the rating ICRA AA; Stable/ ICRA...

Read more

29 Nov 2025 12:13

News

Natco Pharma slides after receiving seven USFDA observations for Chennai API plant

According to the company's exchange filing, the inspection was carried out between 17 Nove...

Read more

24 Nov 2025 09:34

News

Natco Pharma concludes USFDA inspection of its API unit in Chennai

Natco Pharma today announced conclusion of US FDA Inspection at its Manali, Chennai, Activ...

Read more

21 Nov 2025 16:39

News

Board of Natco Pharma recommends interim dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 1...

Read more

14 Nov 2025 16:01

News

Natco Pharma to conduct board meeting

Natco Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2...

Read more

10 Nov 2025 14:53

SWOT Analysis Of Natco Pharma Ltd

Strength

4

S

Weakness

3

W

Opportunity

1

O

Threats

1

T

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Natco Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Reddys Laboratories Ltd and Natco Pharma Ltd

Which company has a larger market capitalization, Dr Reddys Laboratories Ltd or Natco Pharma Ltd?

Market cap of Dr Reddys Laboratories Ltd is 106,164 Cr while Market cap of Natco Pharma Ltd is 16,522 Cr

What are the key factors driving the stock performance of Dr Reddys Laboratories Ltd and Natco Pharma Ltd?

The stock performance of Dr Reddys Laboratories Ltd and Natco Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Reddys Laboratories Ltd and Natco Pharma Ltd?

As of December 18, 2025, the Dr Reddys Laboratories Ltd stock price is INR ₹1272.0. On the other hand, Natco Pharma Ltd stock price is INR ₹922.5.

How do dividend payouts of Dr Reddys Laboratories Ltd and Natco Pharma Ltd compare?

To compare the dividend payouts of Dr Reddys Laboratories Ltd and Natco Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions